Sales & Marketing

Latest News


Latest Videos


Shorts

Branding's Hidden Power
0:43
Branding's Hidden Power
3 months ago
by
Michael Christel(+1 more)
Jason Brown, CEO of BPD Healthcare
0:41
MJH Buys BPD: Expanding Reach to Clinicians, Patients
9 months ago
by
Chris Mazzolini

More News

The high cost of medicine in the United States is not a new phenomenon, but its root causes are complex and deeply embedded in the nation’s legal and regulatory architecture. . Credit: Stock.Adobe.com/Cagkan

Analysis of U.S. drug pricing reform in 2026 highlights how the Inflation Reduction Act, Medicare drug price negotiation, and most-favored-nation pricing initiatives are reshaping pharmaceutical pricing, limiting patent-driven market exclusivity, accelerating generic and biosimilar competition, and driving strategic shifts in market access, pricing models, and innovation priorities across the biopharma industry.